NASDAQ
SNPS
Last Price
US $446.07
KEY FIGURES
MKT CAP
$87.0B
EPS
TTM
$4.06
PEG
TTM
N/M
P/E
TTM
102.79x
P/S
TTM
12.33x
YIELD
0.00%
GROWTH
Revenue Y/Y
Profit margin
Current Ratio
Capital Returns
2.64%
Return on equity
ROIC: 1.61%
Valuation History
102.8X
Price to Earnings
EV/EBITDA: 35.2X
Cash flow
Profit margin
13.87%
(FY vs FY)
EBITDA Y/Y
23.99%
(FY vs FY)
Cash flow Y/Y
10.14%
(FY vs FY)
Cash Flow (DCF)
Fair Value
Market $446.07
-85.32%
Default assumptions
EBITDA Multiple
Fair Value
Market $446.07
-92.86%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
Synopsys, Inc. cash flow to debt ratio of 10.62% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial stability - Healthy cash flow growth.
Synopsys, Inc.'s free cash flow has increased 5.09% from $1.28G last year to $1.35G, signaling increasing performance
Financial stability - Healthy debt to equity ratio.
Synopsys, Inc.'s debt to equity ratio is 0.36, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.
Financial risk - Healthy debt to equity ratio development.
Synopsys, Inc.'s debt has increased relative to shareholder equity from 0.08 last year to 0.36 today, signaling weakened financials
Financial risk - Net debt/EBITDA.
Synopsys, Inc. has a net debt to EBITDA ratio of 4.56x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk
Financial risk - ICR.
Synopsys, Inc.'s interest coverage ratio is 1.14, which means that the company struggles to meet interest obligations, signaling financial risk.
Financial risk - Profit margin growth.
Synopsys, Inc.'s profit margin has decreased (-75.89%) in the last year from 36.94% to 8.91%, signaling decreasing performance
Financial stability - Short term assets vs short term liabilities.
Synopsys, Inc.'s short-term assets of $6.01G exceed its short-term liabilities of $3.72G
Decreasing performance - ROA.
Synopsys, Inc.'s return on assets of 1.65% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
Synopsys, Inc.'s return on equity of 2.64%, is lower than 15.00%, indicating bad performance
Increasing performance - Earnings quality.
Synopsys, Inc.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation
Increasing performance - Earnings stability.
Synopsys, Inc. had positive net income in 5.00 out of 5 years, indicating stable and consistent earnings
Increasing performance - Free cash flow.
Synopsys, Inc. has positive free cash flow, indicating the company generates cash after capital expenditures
Decreasing performance - FCF yield.
Synopsys, Inc. has a free cash flow yield of 1.55%, which is below the 2.00% threshold, indicating limited cash return relative to market value
Decreasing performance - Healthy earnings growth.
Synopsys, Inc.'s yearly earnings has decreased -41.14% since last year from $2.26G to $1.33G, signaling decreasing performance
Increasing performance - Healthy revenue growth.
Synopsys, Inc.'s yearly revenue has increased 15.12% since last year from $6.13G to $7.05G, signaling increasing performance
Decreasing performance - ROIC.
ROIC 1.61% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
Increasing performance - 3-year revenue CAGR.
Synopsys, Inc.'s 3-year revenue CAGR of 15.19% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
Synopsys, Inc. had revenue growth in 5.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
Synopsys, Inc. had positive ROE in 5.00 out of 5 years, indicating consistent and reliable returns on equity
Overvalued - DCF valuation.
Synopsys, Inc. is overvalued relative to its fair value price of 65.48 based on Discounted Cash Flow model
Overvalued - Earnings yield.
Synopsys, Inc. has an earnings yield of 0.89%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings
Overvalued - EBITDA valuation.
Synopsys, Inc. is overvalued relative to its fair value price of 31.83 based on EBITDA multiple model
Overvalued - EV/EBITDA.
Synopsys, Inc. has an EV/EBITDA ratio of 35.22x, which exceeds the 20.00x threshold, indicating the stock may be overvalued relative to its operating earnings
Overvalued - PEG ratio value.
Synopsys, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Undervalued - P/B ratio.
Synopsys, Inc. has a price-to-book ratio of 2.84x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Overvalued - P/S ratio.
Synopsys, Inc. has a price-to-sales ratio of 10.02x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue